Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Johnson & Johnson CEO Backpedals and Quits Right Before Disbands Council August 16, 2017 World's Smartest Billionaire Upped Position in This Bay Area Biotech March 14, 2017 Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada March 28, 2017
